When Thomas Edison patented the incandescent light bulb in 1880, it wasn't a marvel because of its complexity. Quite the opposite...

Edison's design consisted of a carbon filament, a glass globe, and a few wires – that's it.

Turning that simple object into something affordable for everyday use was another matter entirely.

You see, early light bulbs were made largely by hand. Skilled workers shaped glass, attached filaments, and assembled components step by step. The entire production process was a series of bottlenecks. Output was slow, costs were high, and quality was inconsistent.

Then, over the following decades, manufacturers replaced slow, handcrafted production with continuous, high-speed machines.

Instead of workers forming bulbs one at a time, molten glass flowed from massive tanks through synchronized systems that shaped, sealed, and moved bulbs along without interruption. Light bulbs became more uniform. Production grew exponentially – and so did investment in this new technology.

The first handmade bulbs were made at a rate of about 165 per day. By the 1980s, machines could make 120,000 bulbs per hour.

The cost of light fell by more than 98%.

Nothing magical happened. Engineers didn't "discover" light again.

They simply got rid of unnecessary steps, idle time, excess labor, and unreliable outcomes until production became more efficient. They found they could do more... with less.

Brian Potter explores this concept beautifully in his book The Origins of Efficiency. (It's a great read, especially if you want to know a lot more about light bulbs.)

His point is that progress often looks less like innovation and more like refinement – the quiet, cumulative work of making a system run better.

Investors tend to overlook the value in businesses that run efficiently.

Markets love big stories, new products, and exploding growth. But constant improvement is what builds untold riches.

That's because when a business gets even just a little better, it increases production, widens margins, and reduces capital requirements.

And the companies that do those things consistently are the exact ones that deliver stable returns over time.

The challenge is to find them... and to buy in at a fair price.

When it comes to finding great companies at good values, few analysts do a better job than my friend and founder of our corporate affiliate Chaikin Analytics, Marc Chaikin...

Marc got his start as an analyst on Wall Street more than 50 years ago. He created proprietary stock indicators – like the industry-standard "Chaikin Money Flow" – used by the biggest firms and traders all over the world.

Today, Marc is warning about a swift and potentially unforgiving market move starting in late February. He says it could draw a sharp line between the true long-term winners... and stocks that have been running on hype alone.

But this isn't a sign to get out of the market. Instead, Marc is urging investors to look at companies in emerging sectors with strong earnings quality. And he has a way to help you find these opportunities...

He believes this strategy could unlock multiple chances to double your money in 2026, while helping avoid the kind of losses that often follow major market turning points.

Marc is sharing all the details – including the names of two stocks you should buy today and two you'll want to sell – next Tuesday, February 17.

Reserve your spot for this urgent new briefing here.

Now, let's get to this week's Q&A... And as always, keep sending your comments, questions, and topic suggestions to feedback@healthandwealthbulletin.com. My team and I read every e-mail.

The Benefit of Bond Funds

Q: Do you recommend individual bonds or buying bond funds? – E.P.

A: Thanks for your question, E.P.

As we've written before, adding safe, fixed-income investments – like bonds – to your portfolio can help you sleep well at night. It's a simple way of stabilizing your investment returns and building wealth over time without worry.

When we talk generally about bonds, we mean all types... those issued by the U.S. Treasury, municipal governments, and corporations alike. And that could be in the form of individual bonds or bond funds.

I do like investing in bond-focused funds – like municipal-bond funds, closed-end funds, or exchange-traded funds. With these investments, we're pooling our money with other investors and minimizing the risk from any one or two bad investments.

Since each fund holds dozens of individual bonds, we're instantly diversified. If one bond defaults, we have the safety of the others to keep our value and income relatively constant. That's especially important as volatility and inflation are running rampant today.

With that said, interest rates are getting lower right now. That means if you're buying into a bond fund that gives you exposure to long-dated bonds (maturities of five, 10, even 20 years), your returns will likely suffer.

That's why I recommended you reconsider your positions in long-dated individual bonds and bond funds for the time being.

There are plenty of short-dated bonds and bond funds you can add to your portfolio to guarantee safe returns and help protect your wealth in any market environment.

What We're Reading (and Watching)...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
February 13, 2026

P.S. Our offices are closed next Monday for Presidents Day. Expect your next Health & Wealth Bulletin issue on Tuesday, February 17.

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top